Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$106.71 - $143.18 $242,445 - $325,304
-2,272 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$80.99 - $107.93 $73,376 - $97,784
-906 Reduced 28.51%
2,272 $970,000
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $65,881 - $81,382
-777 Reduced 19.65%
3,178 $1.14 Million
Q4 2020

Feb 08, 2021

SELL
$78.0 - $104.5 $2.57 Million - $3.44 Million
-32,890 Reduced 89.27%
3,955 $1.46 Million
Q3 2020

Oct 30, 2020

BUY
$95.51 - $112.95 $2.61 Million - $3.09 Million
27,345 Added 287.84%
36,845 $15.2 Million
Q3 2019

Nov 13, 2019

BUY
$35.53 - $43.8 $337,535 - $416,100
9,500 New
9,500 $1.42 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.